FLT4 cDNA ORF Clone in Cloning Vector, Human

Price:
Size:
Number:

FLT4 cDNA ORF Clone in Cloning Vector, Human: 製品情報

遺伝子
Human
NCBI 参考シーケンス番号
遺伝子の長さ
3897 bp
シーケンスの特徴
Identical with the Gene Bank Ref. ID sequence except for the point mutation 3437 G/A resulting in the amino acid Arg substitution by His.
製品の特徴
Full length Clone DNA of Human fms-related tyrosine kinase 4.
プラスミド
ベクター
シークエンシングプライマー
M13-47 and RV-M
品質管理
The plasmid is confirmed by full-length sequencing.
スクリーニング
細菌スクリーニング抵抗力
Ampicillin
保存 & 配送
配送方法
Each tube contains lyophilized plasmid.
保存条件
The lyophilized plasmid can be stored at ambient temperature for three months.

FLT4 cDNA ORF ヌクレオチド配列およびアミノ酸配列に関する情報

**Sino Biological guarantees 100% sequence accuracy of all synthetic DNA constructs we deliver, but we do not guarantee protein expression in your experimental system. Protein expression is influenced by many factors that may vary between experiments or laboratories.**

FLT4 cDNA ORF Clone in Cloning Vector, Human: 別名

FLT-4 cDNA ORF Clone, Human; FLT-41 cDNA ORF Clone, Human; FLT41 cDNA ORF Clone, Human; LMPH1A cDNA ORF Clone, Human; PCL cDNA ORF Clone, Human; VEGF Receptor 3 cDNA ORF Clone, Human; VEGFR-3 cDNA ORF Clone, Human; VEGFR3 cDNA ORF Clone, Human

FLT4 背景情報

Vascular endothelial growth factor receptor 3 (VEGFR3), also known as FLT-4, together with the other two members VEGFR1 (FLT-1) and VEGFR2 (KDR/Flk-1) are receptors for vascular endothelial growth factors (VEGF) and belong to the class III subfamily of receptor tyrosine kinases (RTKs). The VEGFR3 protein is expressed mainly on lymphatic vessels but it is also up-regulated in tumor angiogenesis. Mutations in VEGFR3 have been identified in patients with primary lymphoedema. The VEGF-C/VEGF-D/VEGFR3 signaling pathway may provide a target for antilymphangiogenic therapy in prostate cancer, breast cancer, gastric cancer, lung cancer, non-small cell lung cancer (NSCLC), and so on.
完全な名称
fms related tyrosine kinase 4
参考文献
  • Shushanov S, et al. (2000)VEGFc and VEGFR3 expression in human thyroid pathologies. Int J Cancer.86(1): 47-52.
  • Iljin K, et al. (2001) VEGFR3 gene structure, regulatory region, and sequence polymorphisms. FASEB J. 15(6): 1028-36.
  • Liu XE, et al. (2004) Expression and significance of VEGF-C and FLT-4 in gastric cancer. World J Gastroenterol. 10(3): 352-5.
  • Stearns ME, et al. (2004) Expression of a flt-4 (VEGFR3) splicing variant in primary human prostate tumors. VEGF D and flt-4t(Delta773-1081) overexpression is diagnostic for sentinel lymph node metastasis. Lab Invest. 84(6): 785-95.
カートに追加しました カートに追加しませんでした カートを更新しています。少々お待ちください